Are Investors Undervaluing ResMed Inc. (NYSE:RMD) By 26%?

Published on 18 Feb 2025 on Simply Wall St. · via Yahoo Finance

In this calculation we've used 6.9%, which is based on a levered beta of 0.955. Beta is a measure of...

Read the rest of the article

Start tracking your investments with Statfolio

Some better-ranked stocks from the broader medical space are Quest Diagnostics DGX, ResMed RMD an...

Zacks · via Yahoo Finance 19 Feb 2025

In this calculation we've used 6.9%, which is based on a levered beta of 0.955. Beta is a measure...

Simply Wall St. · via Yahoo Finance 18 Feb 2025

According to InvestingPro data, ResMed maintains a perfect Piotroski Score of 9, indicating...

Investing.com 13 Feb 2025

Free Report) , popularly known as PacBio, delivered an adjusted loss per share of 20 cents in...

Zacks 13 Feb 2025

Some better-ranked stocks in the broader medical space that have announced quarterly results are...

Zacks · via Yahoo Finance 13 Feb 2025

(Hint: Most of them are flying under the radar). Insiders At ResMed Have Sold Stock Recently The...

Simply Wall St. · via Yahoo Finance 2 Feb 2025

ResMed Inc.’s (RMD Quick QuoteRMD - Free Report) adjusted earnings per share (EPS) in the second...

Zacks 30 Jan 2025

Key Picks Some better-ranked stocks in the broader medical space are Cardinal Health, Inc. CAH,...

Zacks · via Yahoo Finance 28 Jan 2025

INGN and Yuwell collaborate to expand and enhance Inogen's innovation pipeline through R&D...

Zacks · via Yahoo Finance 28 Jan 2025

ClearPoint achieves FDA 510(k) clearance for its Navigation Software Version 3.0, designed to...

Zacks · via Yahoo Finance 28 Jan 2025